Tradestie Institutional Equity Comparison Engine
QLTI vs MYGN โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
MYGN Overall Edge
MYGN Captures Institutional Edge (3โ1 Pillars ยท 7โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Myriad Genetics Inc (MYGN) driven by superior Valuation, Growth & Margin, Options & Structure while QLTI counters with relative strength in Momentum & Technical. Fundamentally, QLTI trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus MYGN at 54.0x Forward P/E and -13.3% operating margin (-1.5% YoY). In options structure, QLTI sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MYGN sits in SURGE (22nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
MYGN
QLTI N/M vs MYGN 54.0x Fwd P/E
Growth & Margin Winner
MYGN
Op Margin N/A vs -13.3% ยท YoY N/A vs -1.5%
Momentum & Technical Winner
QLTI
1Y +7.0% vs -12.3% ยท 52W Pos 86% vs 53%
Options & Structure Winner
MYGN
UNCLASSIFIED (N/A IV) vs SURGE (22nd %ile IV)
QLTI
NYSE Arca
GMO International Quality ETF
Institutional Equity
$28.11
-0.81% 1D
Market Cap
N/A
1M Return
+2.85%
1Y Return
+6.95%
Forward P/E
N/M
Unified AI Score
47.8 / 100
HOLD
Tech 50.0
Fund 35.0
Flow 50.0
Mom 11.1
MYGN
NASDAQ
Myriad Genetics Inc
In Vitro & In Vivo Diagnostic Substances
$5.57
-1.59% 1D
Market Cap
$542.9M
1M Return
+39.95%
1Y Return
-12.28%
Forward P/E
54.0x
Unified AI Score
46.2 / 100
HOLD
Tech 30.0
Fund 43.0
Flow 56.0
Mom 50.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
QLTI +6.95%
MYGN -12.28%
Spread: +20.35 pp (QLTI Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
QLTI TTM Op. Margin: N/A
MYGN TTM Op. Margin: -13.3%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on QLTI vs MYGN. Trailing 12-month operating profitability (QLTI N/A vs MYGN -13.3%) and valuation multiples (QLTI N/M vs MYGN 54.0x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | QLTI | MYGN | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | N/A | $542.9M | Larger Scale | MYGN |
| Trailing P/E Ratio Valuation | N/M | 54.0x | Lower Multiple | MYGN |
| Forward P/E Ratio Valuation | N/M | 54.0x | Lower Multiple | MYGN |
| Revenue Growth (YoY) Growth | N/A | -1.5% | Higher Growth | MYGN |
| Operating Margin (TTM) Profitability | N/A | -13.3% | Higher Margin | MYGN |
| Net Profit Margin Profitability | N/A | -16.1% | Higher Margin | MYGN |
| Return on Equity (ROE) Capital Efficiency | N/A | -40.2% | Higher ROE | MYGN |
| 52-Week Range Position Momentum | 86% ($24โ$29) | 53% ($3โ$8) | Stronger Trend | QLTI |
| Beta / 30D Volatility Risk Regime | 0.81ฮฒ ยท 16% Vol | 0.68ฮฒ ยท 122% Vol | Lower Realized Risk | QLTI |
| Unified Institutional Score Composite Signal | 47.8 / 100 (HOLD) | 46.2 / 100 (HOLD) | Higher Composite | QLTI |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full QLTI vs MYGN Buy Guide
QLTI
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
MYGN
SURGE
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
22nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither QLTI nor MYGN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.